Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer

Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World

Farin Kamangar, Graça M. Dores, William F. Anderson · Journal of Clinical Oncology · 2006 · 3.5K citations

Medicine, Oncology, Preventive Medicine +17

CD44 is the principal cell surface receptor for hyaluronate

Alejandro Aruffo, Ivan Stamenkovic, Michael Melnick et al. · Cell · 1990 · 2.5K citations

Life Sciences, Cell Biology, Molecular Biology +10

Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis

Tsung-Cheng Chang, Erik A. Wentzel, Oliver A. Kent et al. · Molecular Cell · 2007 · 2K citations · Full text

Life Sciences, Genetics, Molecular Biology +14

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

Can Liu, Kevin Kelnar, Bigang Liu et al. · Nature Medicine · 2011 · 1.4K citations · Full text

Medicine, Molecular Biology, Oncology +14

MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells

Qing Ji, Xinbao Hao, Min Zhang et al. · PLoS ONE · 2009 · 683 citations · Full text

Medicine, Cancer Biology, Oncology +17